MYREXIS

DEAD

Serial Number

77945122

Owner

MYREXIS, INC.

Attorney

Michael E. Mangelson

First Use Date

May 19, 2011

Filing Date

Feb 25, 2010

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

MYREXIS Trademark

Serial Number: 77945122 • Registration: 4049986

MYREXIS is a trademark filed by MYREXIS, INC. on February 25, 2010. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

MYREXIS, INC. (9 trademarks)

305 Chipeta Way
SALT LAKE CITY, UT 84108

Entity Type: 03

Myriad Pharmaceuticals, Inc. (10 trademarks)

320 Wakara Way
Salt Lake City, UT 84108

Entity Type: 03

Legal Representation

Attorney of Record

Michael E. Mangelson

566 trademarks filed View all →

Trademark Details

Filing Date

February 25, 2010

Registration Date

November 1, 2011

First Use Anywhere

May 19, 2011

First Use in Commerce

May 19, 2011

Published for Opposition

July 27, 2010

Cancellation Date

February 19, 2016

Goods & Services

Pharmaceutical preparations and substances for the treatment of viral, bacterial, infectious, genetic, auditory, hematological, reproductive, lymphatic, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for use in effecting analgesia and in pain management; pharmaceutical products for the prevention and treatment of cancer

Filing History

CANCELLED SECTION 18-TOTAL

Feb 19, 2016 C18.

CANCELLATION TERMINATED NO. 999999

Feb 19, 2016 CANT

CANCELLATION GRANTED NO. 999999

Feb 18, 2016 CANG

CANCELLATION INSTITUTED NO. 999999

Oct 15, 2015 PETC

REGISTERED-PRINCIPAL REGISTER

Nov 1, 2011 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 27, 2011 SUNA

LAW OFFICE REGISTRATION REVIEW COMPLETED

Sep 26, 2011 REGV

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 26, 2011 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Sep 22, 2011 SUPC

USE AMENDMENT FILED

Sep 20, 2011 IUAF

TEAS STATEMENT OF USE RECEIVED

Sep 20, 2011 EISU

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Aug 31, 2011 ASGN

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 23, 2011 EXRA

SOU EXTENSION 1 GRANTED

Mar 22, 2011 EX1G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 22, 2011 AITU

SOU EXTENSION 1 FILED

Mar 3, 2011 EXT1

PAPER RECEIVED

Mar 3, 2011 MAIL

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 21, 2010 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 27, 2010 NPUB

PUBLISHED FOR OPPOSITION

Jul 27, 2010 PUBO

LAW OFFICE PUBLICATION REVIEW COMPLETED

Jun 21, 2010 PREV

ASSIGNED TO LIE

Jun 21, 2010 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 4, 2010 CNSA

EXAMINER'S AMENDMENT ENTERED

Jun 4, 2010 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jun 4, 2010 GNEN

EXAMINERS AMENDMENT E-MAILED

Jun 4, 2010 GNEA

EXAMINERS AMENDMENT -WRITTEN

Jun 4, 2010 CNEA

ASSIGNED TO EXAMINER

Jun 1, 2010 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 3, 2010 NWOS

NEW APPLICATION ENTERED

Mar 1, 2010 NWAP

Related Trademarks

More from this Owner

MYREXIS PHARMACEUTICALS

MYRXS PHARMACEUTICALS

MYRXS

More in Same Class

QGEL

MY5-FU BECAUSE NO TWO PATIENTS ARE ALIKE